4.1 Article

Nicotine, cocaine, amphetamine, morphine, and ethanol increase norepinephrine output in the bed nucleus of stria terminalis of freely moving rats

Journal

ADDICTION BIOLOGY
Volume 26, Issue 1, Pages -

Publisher

WILEY
DOI: 10.1111/adb.12864

Keywords

addiction; BNST; dopamine; microdialysis; norepinephrine

Funding

  1. Fondazione Banco di Sardegna [F71/17000220002]

Ask authors/readers for more resources

The bed nucleus of stria terminalis (BNST), an important limbic area, is involved in neuroendocrine, behavioral responses, and stress regulation. Drugs of abuse increase norepinephrine transmission in the BNST, contributing to the development of stress-induced drug seeking behavior.
The bed nucleus of stria terminalis (BNST) is a complex limbic area involved in neuroendocrine and behavioural responses and, in particular, in the modulation of the stress response. BNST is innervated by dopamine and norepinephrine, which are known to be involved in drug addiction. It is also known that several drugs of abuse increase dopamine transmission in the BNST, but there has been less research regarding the effect on norepinephrine transmission. Here, we have used the microdialysis technique to investigate the effect of several drugs of abuse on norepinephrine transmission in the BNST of freely moving rats. We observed that nicotine (0.2-0.4 mg/kg), cocaine (2.5-5 mg/kg), amphetamine (0.25-0.5 mg/kg), and ethanol (0.5-1.0 g/kg), dose-dependently increased norepinephrine output while the effect of morphine at 3.0 was lower than that of 1.0 mg/kg. These results suggest that many drugs of abuse, though possessing diverse mechanisms of action, share the property of increasing norepinephrine transmission in the BNST. Furthermore, we suggest that the recurring activation of NE transmission in the BNST, due to drug administration, contributes to the alteration of the function that BNST assumes in how the behavioural response to stress manifests, favouring the establishment of the stress-induced drug seeking.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Clinical Neurology

Immunomodulatory Drugs Alleviate L-Dopa-Induced Dyskinesia in a Rat Model of Parkinson's Disease

Laura Boi, Augusta Pisanu, Nigel H. Greig, Michael T. Scerba, David Tweedie, Giovanna Mulas, Sandro Fenu, Ezio Carboni, Saturnino Spiga, Anna R. Carta

MOVEMENT DISORDERS (2019)

Article Immunology

Beneficial effects of curtailing immune susceptibility in an Alzheimer's disease model

Giulia Di Benedetto, Chiara Burgaletto, Anna R. Carta, Salvatore Saccone, Laurence Lempereur, Giovanna Mulas, Carla Loreto, Renato Bernardini, Giuseppina Cantarella

JOURNAL OF NEUROINFLAMMATION (2019)

Article Geriatrics & Gerontology

Neuroprotection by the Immunomodulatory Drug Pomalidomide in the Drosophila LRRK2WD40 Genetic Model of Parkinson's Disease

Maria Antonietta Casu, Ignazia Mocci, Raffaella Isola, Augusta Pisanu, Laura Boi, Giovanna Mulas, Nigel H. Greig, Maria Dolores Setzu, Anna R. Carta

FRONTIERS IN AGING NEUROSCIENCE (2020)

Article Pharmacology & Pharmacy

Trimethyl Chitosan Hydrogel Nanoparticles for Progesterone Delivery in Neurodegenerative Disorders

Maria Cristina Cardia, Anna Rosa Carta, Pierluigi Caboni, Anna Maria Maccioni, Sara Erbi, Laura Boi, Maria Cristina Meloni, Francesco Lai, Chiara Sinico

PHARMACEUTICS (2019)

Review Biochemical Research Methods

Advances in modelling alpha-synuclein-induced Parkinson's diseases in rodents: Virus-based models versus inoculation of exogenous preformed toxic species

A. R. Carta, L. Boi, A. Pisanu, M. F. Palmas, E. Carboni, A. De Simone

JOURNAL OF NEUROSCIENCE METHODS (2020)

Article Medicine, Research & Experimental

Can pioglitazone be potentially useful therapeutically in treating patients with COVID-19?

Elena Carboni, Anna R. Carta, Ezio Carboni

MEDICAL HYPOTHESES (2020)

Article Biochemistry & Molecular Biology

Metabolomics Fingerprint Induced by the Intranigral Inoculation of Exogenous Human Alpha-Synuclein Oligomers in a Rat Model of Parkinson's Disease

Federica Murgia, Luigi Atzori, Ezio Carboni, Maria Laura Santoru, Aran Hendren, Augusta Pisanu, Pierluigi Caboni, Laura Boi, Giuliana Fusco, Anna R. Carta

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Neurosciences

Repurposing Ketamine in Depression and Related Disorders: Can This Enigmatic Drug Achieve Success?

Ezio Carboni, Anna R. Carta, Elena Carboni, Antonello Novelli

Summary: Repurposing ketamine in the therapy of depression could lead to a breakthrough in understanding the etiology of depression. The use of ketamine as a fast-acting antidepressant in treatment-resistant patients has sparked interest in its mechanism of action and potential effects. Further research is needed to explore its clinical applications and long-term implications.

FRONTIERS IN NEUROSCIENCE (2021)

Review Neurosciences

Repurposing Immunomodulatory Imide Drugs (IMiDs) in Neuropsychiatric and Neurodegenerative Disorders

Yoo Jin Jung, David Tweedie, Michael T. Scerba, Dong Seok Kim, Maria Francesca Palmas, Augusta Pisanu, Anna R. Carta, Nigel H. Greig

Summary: Neuroinflammation plays a crucial role in the pathology and progression of major psychiatric and neurodegenerative disorders, with a lack of effective drug treatments available for most neurological conditions. It has been identified as a key factor in the progression of various neurological disorders, offering new avenues for drug target identification in ongoing research.

FRONTIERS IN NEUROSCIENCE (2021)

Article Clinical Neurology

Repurposing Pomalidomide as a Neuroprotective Drug: Efficacy in an Alpha-Synuclein-Based Model of Parkinson's Disease

Maria Francesca Palmas, Anna Ena, Chiara Burgaletto, Maria Antonietta Casu, Giuseppina Cantarella, Ezio Carboni, Michela Etzi, Alfonso De Simone, Giuliana Fusco, Maria Cristina Cardia, Francesco Lai, Luca Picci, David Tweedie, Michael T. Scerba, Valentina Coroneo, Renato Bernardini, Nigel H. Greig, Augusta Pisanu, Anna R. Carta

Summary: In this study, the researchers tested the disease-modifying properties of the immunomodulatory drug pomalidomide in a rat model of Parkinson's disease. The results showed that pomalidomide had neuroprotective effects and inhibited the inflammatory response caused by the disease. These findings provide evidence for the potential repurposing of pomalidomide for clinical testing in Parkinson's disease patients.

NEUROTHERAPEUTICS (2022)

Article Cell Biology

The Intranigral Infusion of Human-Alpha Synuclein Oligomers Induces a Cognitive Impairment in Rats Associated with Changes in Neuronal Firing and Neuroinflammation in the Anterior Cingulate Cortex

Maria Francesca Palmas, Michela Etzi, Augusta Pisanu, Chiara Camoglio, Claudia Sagheddu, Michele Santoni, Maria Francesca Manchinu, Mauro Pala, Giuliana Fusco, Alfonso De Simone, Luca Picci, Giovanna Mulas, Saturnino Spiga, Maria Scherma, Paola Fadda, Marco Pistis, Nicola Simola, Ezio Carboni, Anna R. Carta

Summary: The study demonstrates that intracerebral infusion of pre-formed human alpha synuclein oligomers (H-alpha SynOs) provides a valid model for studying cognitive symptoms in Parkinson's disease, accompanied by neuroinflammation, shedding light on the mechanisms underlying cognitive impairment.

CELLS (2022)

Article Clinical Neurology

Combined measure of salivary alpha-synuclein species as diagnostic biomarker for Parkinson's disease

Fabrizio Angius, Ignazia Mocci, Tommaso Ercoli, Francesco Loy, Laura Fadda, Maria Francesca Palmas, Giada Cannas, Aldo Manzin, Giovanni Defazio, Anna R. Carta

Summary: Parkinson's disease (PD) diagnosis still relies on post-mortem neuropathological diagnosis due to bias in current diagnostic methods. This study explores the potential of α-synuclein (α-syn) species in saliva as biomarkers for PD. The results show that phosphorylated α-syn (p-α-syn) is the most abundant species in saliva, and the ratio of p-α-syn/tot-α-syn and oligomeric α-syn (o-α-syn) concentration can provide more accurate diagnostic accuracy for PD.

JOURNAL OF NEUROLOGY (2023)

Article Biochemistry & Molecular Biology

Modeling Parkinson's Disease Neuropathology and Symptoms by Intranigral Inoculation of Preformed Human α-Synuclein Oligomers

Laura Boi, Augusta Pisanu, Maria Francesca Palmas, Giuliana Fusco, Ezio Carboni, Maria Antonietta Casu, Valentina Satta, Maria Scherma, Elzbieta Janda, Ignazia Mocci, Giovanna Mulas, Anna Ena, Saturnino Spiga, Paola Fadda, Alfonso De Simone, Anna R. Carta

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

No Data Available